Ramirez Asset Management, Inc. Csl LTD Transaction History

Ramirez Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	BUY	$72.7 - $83.25 $386,473 - $442,557	5,316 Added 28.35%	24,067 $1.89 Billion
Q1 2025 May 07, 2025	SELL	$78.15 - $89.58 $238,513 - $273,398	-3,052 Reduced 14.0%	18,751 $1.46 Billion
Q4 2024 Feb 12, 2025	SELL	$86.47 - $101.1 $63,987 - $74,814	-740 Reduced 3.28%	21,803 $1.9 Billion
Q3 2024 Nov 12, 2024	BUY	$97.0 - $105.54 $2.19 Million - $2.38 Million	22,543 New	22,543 $2.24 Billion
Q3 2023 Nov 15, 2023	BUY	$80.15 - $92.62 $2.43 Million - $2.81 Million	30,292 New	30,292 $2.45 Billion

64.1K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $55.9B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Ramirez Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Ramirez Asset Management, Inc. with notifications on news.